The persisting political climate has made any objective discussion about hydroxychloroquine "impossible," two Henry Ford Health System executives wrote in an open letter dated Aug. 3. Adnan Munkarah, MD, executive vice president and chief clinical officer at the Detroit-based system, along with Steven Kalkanis, MD, senior vice president and chief academic officer for Henry Ford, penned the letter in response to comments by Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, that their study on hydroxychloroquine was "flawed." The situation is a bellwether for the kind of tension other systems may face when their clinical...